Goldman Sachs
SNY icon

Goldman Sachs’s Sanofi SNY Stock Holding History

Goldman Sachs’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-30,000
Closed -$1.46M – 6056
2024
Q2 		$1.46M Buy
+30,000
New +$1.45M ﹤0.01% 4178
2022
Q4 		– Sell
-122,000
Closed -$4.64M – 6244
2022
Q3 		$4.64M Buy
+122,000
New +$5.44M ﹤0.01% 3194
2021
Q4 		– Sell
-71,700
Closed -$3.46M – 6682
2021
Q3 		$3.46M Buy
+71,700
New +$3.65M ﹤0.01% 3690
2020
Q1 		– Sell
-25,700
Closed -$1.29M – 5540
2019
Q4 		$1.29M Buy
+25,700
New +$1.2M ﹤0.01% 3954
2018
Q1 		– Sell
-4,900
Closed -$211K – 6362
2017
Q4 		$211K Sell
4,900
-10,000
-67% -$461K ﹤0.01% 5402
2017
Q3 		$742K Sell
14,900
-18,300
-55% -$886K ﹤0.01% 4813
2017
Q2 		$1.59M Buy
33,200
+8,600
+35% +$411K ﹤0.01% 4020
2017
Q1 		$1.11M Sell
24,600
-13,700
-36% -$581K ﹤0.01% 4284
2016
Q4 		$1.55M Sell
38,300
-20,800
-35% -$820K ﹤0.01% 4083
2016
Q3 		$2.26M Buy
59,100
+21,200
+56% +$851K ﹤0.01% 3718
2016
Q2 		$1.59M Buy
37,900
+18,100
+91% +$742K ﹤0.01% 3808
2016
Q1 		$795K Sell
19,800
-7,200
-27% -$289K ﹤0.01% 4287
2015
Q4 		$1.15M Buy
27,000
+9,500
+54% +$437K ﹤0.01% 4154
2015
Q3 		$831K Sell
17,500
-21,100
-55% -$1.07M ﹤0.01% 4657
2015
Q2 		$1.91M Buy
38,600
+6,800
+21% +$345K ﹤0.01% 3868
2015
Q1 		$1.57M Buy
31,800
+7,300
+30% +$349K ﹤0.01% 4019
2014
Q4 		$1.12M Sell
24,500
-154,400
-86% -$7.49M ﹤0.01% 4444
2014
Q3 		$10.1M Sell
178,900
-43,800
-20% -$2.35M ﹤0.01% 2358
2014
Q2 		$11.8M Buy
222,700
+131,300
+144% +$6.97M ﹤0.01% 2232
2014
Q1 		$4.78M Sell
91,400
-21,200
-19% -$1.07M ﹤0.01% 3075
2013
Q4 		$6.04M Sell
112,600
-80,500
-42% -$4.15M ﹤0.01% 2866
2013
Q3 		$9.78M Buy
193,100
+163,700
+557% +$8.33M ﹤0.01% 2279
2013
Q2 		$1.51M Buy
+29,400
New +$1.57M ﹤0.01% 3997

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Goldman Sachs's SNY Position: Q1 2026 in Review

Goldman Sachs increased its Sanofi (SNY) stake by 31% in Q1 2026, buying an estimated $28.2M and bringing the position to 2,582,456 shares worth $124M. The position accounts for 0.01% of the portfolio, ranked #905.

Goldman Sachs first reported a position in SNY in Q2 2013 and has held it in 52 quarters since. The position peaked at $211M in Q3 2024. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Goldman Sachs held 2,582,456 shares of Sanofi worth $124M as of Q1 2026.
  • Goldman Sachs bought 604,853 Sanofi shares in Q1 2026, an estimated $28.2M.
  • Sanofi made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #905 holding.
  • Goldman Sachs first reported a position in Sanofi in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Sanofi position peaked at $211M in Q3 2024.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.